@OldFart do you see this in the reply box? i've also been using an image hosting site like http://www.imgur.com/ to post images to the board.
Frontrunning: April 6 Cruz, Sanders score decisive victories in Wisconsin (Reuters) Clinton Can’t Get to New York Fast Enough After New Sanders Win (BBG) Trump, Clinton Have Single-Digit Leads in Pennsylvania (BBG) Panama law firm says data hack was external, files complaint (Reuters) ‘Panama Papers’ Puts Spotlight on Boom in Offshore Services (WSJ) Barclays partners with Goldman-backed bitcoin payments app (FT) China Inc. Scraps $7 Billion of Bond Offerings as Defaults Rise (BBG) Activists Reap Olive Garden Bounty (WSJ) Russia sees oil price of $45-$50 per barrel 'acceptable' as it prepares for freeze deal (Reuters) Deposition ordered for woman in debunked Rolling Stone rape article (Reuters) Some Asking If Disney CEO Will Extend Tenure (WSJ) NYU Graduates Seeking $11 Billion of Gold in Ransacked Mine (BBG) Oil glut up close: How Cushing copes with full crude tanks (Reuters) PayPal pulls North Carolina plan after transgender bathroom law (Reuters) Currency Traders Brace for Wild Ride as Volatility Curves Invert (BBG) Zika mystery deepens with evidence of nerve cell infections (Reuters) Rising U.S. inflation would take a bite out of the dollar (Reuters) Spoiler: 4/6/16 Wednesday Movers: STZ, AGN, PFE, WFC, CSCO, PLCM, WYNN, CREE, AMZN, JNJ, FB, AAPL & more 4/6/16 Wednesday Movers: STZ, AGN, PFE, WFC, CSCO, PLCM, WYNN, CREE, AMZN, JNJ, FB, AAPL & more source: cnbc.com Check out which companies are making headlines before the bell on Wednesday Constellation Brands — The spirits maker reported quarterly profit of $1.19 per share, 5 cents above estimates, with revenue also beating forecasts. Constellation also announced an agreement to buy the Prisoner Wine Co.'s brand portfolio from Huneeus Vintners for an undisclosed amount. Allergan, Pfizer — Pfizer abandoned its $160 billion merger with Allergan following the Treasury's new rules aimed at discouraging so-called corporate tax inversions. Pfizer will pay a deal termination fee of $150 million to reimburse Allergan for expenses, per their merger agreement. Wells Fargo — Guggenheim downgraded the bank's shares to "neutral" from "buy." The firm said the stock is fully valued relative to its peer group, among other factors. At the same time, Guggenheim designatedAlly Financial as a "Best Idea," citing an improving cost of funds and stable operating expenses. Cisco Systems — JPMorgan Chase upgraded Cisco to "neutral" from "underweight," saying earnings estimates are conservative enough to offset the risk that Cisco's switching products are becoming commoditized. Polycom — The provider of video and voice technology is in advanced talks to be acquired by mobile communications company Mitel, according to a Bloomberg report. The price is said to be $12.50 per share, compared to Tuesday's close for Polycom of $10.84 per share. Wynn Resorts — Wynn released preliminary quarterly results showing a further slowdown in its already slumping Macau operations, while results in the Las Vegas market were relatively flat for the casino operator. Cree — Cree preannounced quarterly results which are well below its prior guidance as well as the Street's consensus estimates. Cree, which specializes in LED offerings, points to lower commercial orders in its lighting products business. Amazon.com — Amazon will release a new Kindle e-reader with a rechargeable protective case, according to multiple sources. Fiat Chrysler — The automaker will spend $500 million to revamp its Argentina plant, where it is planning to produce a new model starting next year. Most of the cars produced at the plant will be exported out of the country. Johnson & Johnson — The Food and Drug Administration approved a "biosimilar" to Johnson & Johnson's rheumatoid arthritis treatment Remicade. The new drug comes from South Korean drugmaker Celltrion, in partnership with Pfizer. Facebook — Facebook's WhatsApp standalone messaging app is now fully encrypted and unreadable to anyone, including the authorities, according to the unit's CEO Jan Koum. Apple — Apple was rated "strong buy" in new coverage at Needham, which set a $150 per share price target. Needham said Apple dominates the wealthiest segment of a rapidly growing consumer market, and the iOS universe has fewer competitive pressures and higher pricing power. _____________________________________________________________________________________________________________________ Here are this morning's most active trending pre-market discussions- (stock symbols are clickable!) TRXC SRPT STZ DRWI PFE CREE NUGT BHI NFLX SUNE GPN MAT USO AGN DUK F RTN NVDA CMCSA DUST MRVL JDST LLY HAL _____________________________________________________________________________________________________________________ Here are today's earnings reports- _____________________________________________________________________________________________________________________ Here are today's economic events- _____________________________________________________________________________________________________________________ Markets Now- _____________________________________________________________________________________________________________________ Good trading to everyone in here on this Wednesday!
Man the pharma sector went off today. Of course I screwed the pooch not holding my ANAC or VRTX long enough. Been in and out of those two suckers a few times the last two weeks. Just got extremely impatient.
ES pushing into the close! 2057 and climbing! 2035 was the support today, Im no sure it holds this week.
opk had a good day today, because of the strength in biotech sector, man what a crazy move ibb has had over the past week. missed my fill on gdx at 2pm, will have to wait for another entry point. i wanted to buy allergan yesterday, but i didnt pull the trigger at 231, now im kicking myself, would have been a quick trade.
Our markets really are decoupling from the Yen. For the last couple of years a weak Yen mostly indicated risk on and a strong Yen indicated risk off, but now we keep rallying despite the Yen keeps rising against the dollar.
What a day. VRX broke many short's heart today. 19% during the day and another 3.5-4% after hours on 1.7M volume. I bought some yesterday and will probably continue to hold. Hopefully I wont regret that decision. Pharma companies have been trying to catch up to the rest of the market. OPK did well too to make things even greener for me. I should have kept my IBB position longer though. Had to sell and diversify as I was focusing too much on biotech with OPK and now VRX. Let's hope this run can continue
yeah IBB playing catch up now, which makes me wonder if its the final stretch of this run. Money is looking for some place to go and IBB was the most beaten down of the sectors.
Keeping an eye on the IWM. Small caps will be first to fail if this market is in trouble, so if IWM can crack over this resistance..
transports have been getting wrecked lately. maybe its a sign of things to come in the major indicies.
next monday kicks it off again @Baggi good eye as usual @Ken34 here's the 10day comparison of the major indices ... transports which had initially lead the move higher are now lagging behind again ... what's that mean for the overall markets going forward? significant or nothing at all?
Earnings numbers this quarter can't be good. I reckon they will be pretty bad or at least they should be because China's export numbers were bad these last 3 months unless they are still selling stock from last year. Container shipping prices are now roughly 50% off of what they usually go for out of China to Los Angeles which means they are discounting shipping costs big time to try and boost exports out of China. Shipping now is very cheap compared to what prices were last year.
IWM vs SPX has been flat indicating weakness in recovery to begin with. Their chart never even reached your trendline. In fact, look at the DAX, NIKK, FTSE, et al. They don't look much like recovery to me.
